Xueqi Li

1.1k total citations
45 papers, 758 citations indexed

About

Xueqi Li is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xueqi Li has authored 45 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xueqi Li's work include Coronary Interventions and Diagnostics (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Chronic Kidney Disease and Diabetes (5 papers). Xueqi Li is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Chronic Kidney Disease and Diabetes (5 papers). Xueqi Li collaborates with scholars based in China, United States and Netherlands. Xueqi Li's co-authors include Xiaopeng Bai, Lingqi Zhou, Song Chen, Genfu Tang, Xiaobin Wang, Xiaowei Ren, Qiang Li, Houxun Xing, Xiping Xu and Guangyun Mao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Xueqi Li

40 papers receiving 737 citations

Peers

Xueqi Li
Wilfried Dinh Germany
Mauricio Ibacache Chile
Valentina Milani Italy
Rıdvan Yalçin Türkiye
Jan‐Christian Reil Germany
Amanda J. Cox United States
Gorizio Pieretti Italy
Y Takemura Japan
Satoki Homma Japan
Jarkko Magga Finland
Wilfried Dinh Germany
Xueqi Li
Citations per year, relative to Xueqi Li Xueqi Li (= 1×) peers Wilfried Dinh

Countries citing papers authored by Xueqi Li

Since Specialization
Citations

This map shows the geographic impact of Xueqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqi Li more than expected).

Fields of papers citing papers by Xueqi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqi Li. The network helps show where Xueqi Li may publish in the future.

Co-authorship network of co-authors of Xueqi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqi Li. A scholar is included among the top collaborators of Xueqi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqi Li. Xueqi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Xueqi, Bo Jin, Sixiu Liu, et al.. (2025). Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic nephropathy. Acta Pharmacologica Sinica. 46(6). 1692–1705. 2 indexed citations
3.
Li, Xueqi, et al.. (2025). Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial. Drug Design Development and Therapy. Volume 19. 5961–5972. 1 indexed citations
4.
Li, Xueqi, Iwaki Akiyama, Jing Liang, et al.. (2025). Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients. World Journal of Gastroenterology. 31(11). 102795–102795.
5.
Zhang, Yumeng, Xinyu Du, Hao Chen, et al.. (2025). CmFDa‐mediated epigenetic regulation of flowering in chrysanthemum. Plant Biotechnology Journal. 23(7). 2720–2733.
6.
Yan, Fang, Liyun Xue, Yan Zhang, et al.. (2024). Nomogram based on liver stiffness and spleen area with ultrasound for posthepatectomy liver failure: A multicenter study. World Journal of Gastroenterology. 30(27). 3314–3325.
7.
Lü, Jian, Xueqi Li, Peipei Chen, et al.. (2023). Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway. Acta Pharmacologica Sinica. 45(2). 366–377. 24 indexed citations
8.
Zeng, Zhiwen, Xueqi Li, Shang-Hang Xie, et al.. (2023). Association between hypertension and Epstein-Barr virus reactivation among the population in a high-risk area for nasopharyngeal carcinoma. Virus Research. 331. 199117–199117. 4 indexed citations
9.
Xu, Kai, Bo Xu, Changdong Guan, et al.. (2021). Biodegradable polymer-coated versus durable polymer-coated sirolimus-eluting stents: the final 5-year outcomes of the I-LOVE-IT 2 trial. EuroIntervention. 16(18). e1518–e1526. 3 indexed citations
10.
Chen, Wenjie, Haiyun Wang, Xiaoxia Chen, et al.. (2021). Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population. BMC Cancer. 21(1). 651–651. 18 indexed citations
11.
Wu, Ying, Shuzhen Wei, Ting Wu, et al.. (2020). Endobronchial ultrasound elastography for differentiating between benign and malignant lymph nodes. Minerva Medica. 111(4). 369–370. 1 indexed citations
12.
Lü, Jian, et al.. (2019). Urinary levels of podocyte-derived microparticles are associated with the progression of chronic kidney disease. Annals of Translational Medicine. 7(18). 445–445. 11 indexed citations
13.
14.
Yu, Long Hao, et al.. (2017). Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis. Experimental and Therapeutic Medicine. 14(2). 1568–1576. 16 indexed citations
15.
Zhao, Ying, Yanbo Yu, Xi Yang, et al.. (2017). Association study to evaluate TFPI gene in CAD in Han Chinese. BMC Cardiovascular Disorders. 17(1). 188–188. 6 indexed citations
16.
Zhang, Tong, Lili Zhao, Xue Cao, et al.. (2014). Bioinformatics analysis of time series gene expression in left ventricle (LV) with acute myocardial infarction (AMI). Gene. 543(2). 259–267. 28 indexed citations
17.
Li, Xueqi. (2013). An Analysis of Incidence and Mortality of Gastric Cancer in Cancer Registries of Zhejiang Province,2000~2009. 3 indexed citations
18.
Wei, Shipeng, et al.. (2011). The status of coronary artery lesions in patients with conduction disturbance. Journal of Cardiovascular Medicine. 12(10). 709–713. 8 indexed citations
19.
Chen, Liyan, Jian Guo, Feng Jiang, et al.. (2010). STK39 is an independent risk factor for male hypertension in Han Chinese. International Journal of Cardiology. 154(2). 122–127. 25 indexed citations
20.
Bai, Xiaopeng, et al.. (2009). Influence of the menstrual cycle on nonlinear properties of heart rate variability in young women. American Journal of Physiology-Heart and Circulatory Physiology. 297(2). H765–H774. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilfried Dinh Breakdown of academic impact, for papers by Mauricio Ibacache Breakdown of academic impact, for papers by Valentina Milani Breakdown of academic impact, for papers by Rıdvan Yalçin Breakdown of academic impact, for papers by Jan‐Christian Reil Breakdown of academic impact, for papers by Amanda J. Cox Breakdown of academic impact, for papers by Gorizio Pieretti Breakdown of academic impact, for papers by Y Takemura Breakdown of academic impact, for papers by Satoki Homma Breakdown of academic impact, for papers by Jarkko Magga
Rankless by CCL
2026